Fund Holdings — venBio Partners LLC

Total Portfolio Value
$194.33M
Total Bought
$23.48M
Total Sold
$13.23M
Net Transaction
+$10.26M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
ARTIVA BIOTHERAPEUTICS INC(ARTV)01,519,971+1,519,971023,48412.08%+23,484
ACELYRIN INC3,852,4703,852,470016,98918,9939.77%+2,003
PHARVARIS N V
COM
4,289,3044,289,304080,63979,43840.88%-1,201
ELEVATION ONCOLOGY INC2,434,2550-2,434,2556,5720—-6,572
HARMONY BIOSCIENCES HLDGS IN(HRMY)1,035,396614,594-420,80231,23824,58412.65%-6,654
ALUMIS INC2,826,0482,826,048037,58630,18215.53%-7,404
ALX ONCOLOGY HLDGS INC(ALXO)9,699,9259,699,925058,49117,6549.08%-40,837
Page 1 of 1
venBio Partners LLC — 13F Holdings — Q3 2024 | TickerTrail